mAbxience Research - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsmAbxience Research

mAbxience Research

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Alymsys	Bevacizumab	2021-03-26		Renal cell carcinoma , Colorectal neoplasms , Breast neoplasms , Ovarian neoplasms , Non-small-cell lung carcinoma , Glioblastoma , Fallopian tube neoplasms , Kidney neoplasms , Uterine cervical neoplasms , Peritoneal neoplasms

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

,

,

triple negative breast neoplasms

,

biliary tract neoplasms

,

,

unknown primary neoplasms

,

urologic neoplasms

,

transitional cell carcinoma

,

multiple myeloma

,

b-cell chronic lymphocytic leukemia

,

,

rheumatoid arthritis

,

,

margins of excision

,

,

,

extranodal nk-t-cell lymphoma

,

non-hodgkin lymphoma

,

hereditary sensory and autonomic neuropathies

,

central nervous system neoplasms

,

nervous system neoplasms

,

pathologic neovascularization

,

esophageal neoplasms

,

sex cord-gonadal stromal tumors

,

small cell lung carcinoma

,

erythema multiforme

,

liver neoplasms

,

hepatocellular carcinoma

,

rectal neoplasms

,

renal cell carcinoma

,

,

colonic neoplasms

,

neoplasm metastasis

,

ovarian epithelial carcinoma

,

,

,

,

pancreatic neoplasms

,

uterine cervical neoplasms

,

stomach neoplasms

,

ulcerative colitis

,

,

,

macular degeneration

,

circulating neoplastic cells

,

brain neoplasms

,

malignant mesothelioma

,

inflammatory breast neoplasms

,

b-cell lymphoma

,

retinal diseases

,

diabetic retinopathy

,

vision disorders

,

,

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

mucinous adenocarcinoma

,

ductal carcinoma breast

,

disability evaluation

,

cognition disorders

,

malignant pleural effusion

,

colorectal neoplasms

,

breast neoplasms

,

non-small-cell lung carcinoma

,

,

ovarian neoplasms

,

peritoneal neoplasms

,

fallopian tube neoplasms

,

,

,

adenocarcinoma of lung

,

,

neoadjuvant therapy

,

molecular targeted therapy

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use